Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations-Reference-Cited by-同舟云学术

Helicobacter pylori Antimicrobial Resistance and Gene Variants in High- and Low-Gastric-Cancer-Risk Populations

Published:2021-04-20 Issue:5 Volume:59 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Mannion Anthony¹^ORCID,Dzink-Fox JoAnn¹,Shen Zeli¹,Piazuelo M. Blanca²,Wilson Keith T.²,Correa Pelayo²,Peek Richard M.²,Camargo M. Constanza³,Fox James G.¹⁴^ORCID

Affiliation:

1. Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

2. Vanderbilt University, Nashville, Tennessee, USA

3. Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA

4. Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA

Abstract

Colombia, South America has one of the world’s highest burdens of Helicobacter pylori infection and gastric cancer. While multidrug antibiotic regimens can effectively eradicate H. pylori , treatment efficacy is being jeopardized by the emergence of antibiotic-resistant H. pylori strains.

Funder

HHS | National Institutes of Health

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.03203-20

Reference67 articles.

1. The Human Gastric PathogenHelicobacter pyloriand Its Association with Gastric Cancer and Ulcer Disease

2. Helicobacter pylori persistence: biology and disease

3. Eradication Therapy for Helicobacter pylori